Cell Line Development Has to Evolve

In this Thought Leader article, Campbell Bunce, PhD, CSO of Abzena writes about advances in platform design, genome engineering, and integrated workflows are prompting the industry to reassess long-held assumptions and move away from purely sequential approaches to CLD.

The post Cell Line Development Has to Evolve appeared first on GEN - Genetic Engineering and Biotechnology News.